Vouchers vs. Prizes for Cocaine-Dependent Methadone Patients - 2
NCT00249535 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240
Last updated 2012-03-30
Summary
The purpose of this study is to compare voucher-based contingency management (CM) procedures to a lower-cost CM system that provides opportunities to win prizes. Cocaine-dependent outpatients are randomly assigned to (a) standard treatment, (b) standard treatment plus usual magnitude prize CM, (c) standard treatment plus higher magnitude prize CM, or (d) standard treatment plus voucher CM. Urine and breath samples are collected 2-3x/week for 14 weeks. Follow-up interviews are conducted at 1,3,6 and 9 months following intake during which substance use and psychosocial functioning are assessed.
Conditions
- Cocaine Dependence
Interventions
- BEHAVIORAL
-
Contingency management
Rewards (prizes) for abstinence
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
UConn Health
lead OTHER
Principal Investigators
-
Nancy Petry, Ph.D. · UConn Health
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-03-31
- Primary Completion
- 2011-07-31
- Completion
- 2011-07-31
Countries
- United States
Study Locations
More Related Trials
-
Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 1
NCT00249496 ·Status: COMPLETED ·Phase: NA
-
Contingency Management to Enhance Office-Based Buprenorphine Treatment
NCT04024059 ·Status: COMPLETED ·Phase: NA
-
Automated Prize-based Contingency Management to Increase Counseling Attendance in Opiate-Replacement-Therapy Patients
NCT01229163 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Harnessing Placebo Effects in Methadone Treatment
NCT02941809 ·Status: COMPLETED ·Phase: NA
-
Contingency Management for Drug Use: Does Age Matter?
NCT05521854 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
NCT04927143 ·Status: RECRUITING ·Phase: NA
-
Remote Observed Dosing of Suboxone to Improve Clinical Practice
NCT03769025 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparison of Two Counseling Induction Strategies
NCT01141920 ·Status: COMPLETED ·Phase: NA
-
Interactive Voice Response (IVR) for Methadone Patients
NCT00237406 ·Status: COMPLETED
-
Incentive-based Smoking Cessation for Methadone Patients
NCT00718835 ·Status: COMPLETED ·Phase: PHASE2
-
Incentives to Decrease Opioid Use - Pilot
NCT04235582 ·Status: COMPLETED ·Phase: NA
-
Trial of Methadone Maintenance Versus Methadone Detox in Jail
NCT01874964 ·Status: UNKNOWN ·Phase: NA
-
Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
NCT00000216 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating Three Methods for Helping Syringe Exchangers Begin Methadone Maintenance
NCT01142986 ·Status: COMPLETED ·Phase: NA
-
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1
NCT00033020 ·Status: COMPLETED ·Phase: PHASE3
-
Methadone Oxytocin Option
NCT01728909 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Enhancing Recovery Capital Amid Opioid Use Disorder Pharmacotherapy: A Pilot Randomized Trial
NCT05245513 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence
NCT00555425 ·Status: COMPLETED ·Phase: PHASE4
-
Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics)
NCT03931174 ·Status: COMPLETED ·Phase: NA
-
Clonidine for Relapse Prevention in Buprenorphine-Maintenance Patients
NCT00295308 ·Status: COMPLETED ·Phase: PHASE1
-
Methadone Maintenance for Prisoners
NCT00378079 ·Status: COMPLETED ·Phase: PHASE3
-
Buprenorphine Maintenance for Opioid Addicts - 1
NCT00000202 ·Status: COMPLETED ·Phase: PHASE2
-
Contingency Management for Stimulant Use Disorders
NCT05097547 ·Status: UNKNOWN ·Phase: NA
-
Buprenorphine Maintenance for Opioid Addicts - 2
NCT00000203 ·Status: COMPLETED ·Phase: PHASE2
-
Initiating Substance Use Disorder Treatment for Hospitalized Opioid Use Disorder Patients.
NCT03212794 ·Status: COMPLETED ·Phase: NA